ESC 365 - Welcome and introduction.

Back

Open Access

Welcome and introduction.

Session: Iron deficiency as a therapeutic target in heart failure - new evidence, new guidelines

Topic: Chronic Heart Failure

Speaker: Professor S. Anker (Berlin, DE)

Sponsored by Charité Friends & Sponsors Trust - Supported by an unrestricted educational grant from Vifor Pharma

Event: ESC Congress 2021 - The Digital Experience

Congress Session

About the speaker

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)

107 presentations

3 followers

4 more presentations in this session

New evidence from AFFIRM-AHF ‒ implications for clinical practice.

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Access

Video

New evidence from meta-analyses ‒ lessons to learn on the benefits of intravenous ferric carboxymaltose in heart failure.

Speaker: Professor J. Butler (Jackson, US)

Access

Video

Management of iron deficiency in heart failure - what do the guidelines say?

Speaker: Professor A. Coats (Coventry, GB)

Access

Video

Panel discussion.

Access

Video

Access the full session

Iron deficiency as a therapeutic target in heart failure - new evidence, new guidelines

Speakers: Professor S. Anker, Professor P. Ponikowski, Professor J. Butler, Professor A. Coats

Access

Video

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

Open Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

Open Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: case presentation.

27 August 2021

Welcome and introduction.

About the speaker

Professor Stefan Anker

4 more presentations in this session

New evidence from AFFIRM-AHF ‒ implications for clinical practice.

New evidence from meta-analyses ‒ lessons to learn on the benefits of intravenous ferric carboxymaltose in heart failure.

Management of iron deficiency in heart failure - what do the guidelines say?

Panel discussion.

Access the full session

Iron deficiency as a therapeutic target in heart failure - new evidence, new guidelines

About the event

ESC Congress 2021 - The Digital Experience

Related content

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: case presentation.

This platform is supported by